OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis
Tao Xue, Xin Wu, Shujun Chen, et al.
Sleep Medicine Reviews (2021) Vol. 61, pp. 101573-101573
Closed Access | Times Cited: 68
Tao Xue, Xin Wu, Shujun Chen, et al.
Sleep Medicine Reviews (2021) Vol. 61, pp. 101573-101573
Closed Access | Times Cited: 68
Showing 1-25 of 68 citing articles:
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents
Christoph U. Correll, Marco Solmi, Samuele Cortese, et al.
World Psychiatry (2023) Vol. 22, Iss. 1, pp. 48-74
Open Access | Times Cited: 82
Christoph U. Correll, Marco Solmi, Samuele Cortese, et al.
World Psychiatry (2023) Vol. 22, Iss. 1, pp. 48-74
Open Access | Times Cited: 82
Efficacy and tolerability of pharmacological treatments for insomnia in adults: A systematic review and network meta-analysis
Jing-Li Yue, Xiang-Wen Chang, Jun-Wei Zheng, et al.
Sleep Medicine Reviews (2023) Vol. 68, pp. 101746-101746
Closed Access | Times Cited: 49
Jing-Li Yue, Xiang-Wen Chang, Jun-Wei Zheng, et al.
Sleep Medicine Reviews (2023) Vol. 68, pp. 101746-101746
Closed Access | Times Cited: 49
Management of Insomnia
Charles M. Morin, Daniel J. Buysse
New England Journal of Medicine (2024) Vol. 391, Iss. 3, pp. 247-258
Closed Access | Times Cited: 15
Charles M. Morin, Daniel J. Buysse
New England Journal of Medicine (2024) Vol. 391, Iss. 3, pp. 247-258
Closed Access | Times Cited: 15
The orexin story, sleep and sleep disturbances
Fabio Pizza, Lucie Barateau, Yves Dauvilliers, et al.
Journal of Sleep Research (2022) Vol. 31, Iss. 4
Closed Access | Times Cited: 48
Fabio Pizza, Lucie Barateau, Yves Dauvilliers, et al.
Journal of Sleep Research (2022) Vol. 31, Iss. 4
Closed Access | Times Cited: 48
The orexin story and orexin receptor antagonists for the treatment of insomnia
Clemens Muehlan, Catherine Roch, Cédric Vaillant, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 6
Open Access | Times Cited: 39
Clemens Muehlan, Catherine Roch, Cédric Vaillant, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 6
Open Access | Times Cited: 39
Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 23
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 23
Common Sleep Disorders in Pregnancy
Francesca Facco, Megan Q. Chan, Sanjay R. Patel
Obstetrics and Gynecology (2022)
Closed Access | Times Cited: 31
Francesca Facco, Megan Q. Chan, Sanjay R. Patel
Obstetrics and Gynecology (2022)
Closed Access | Times Cited: 31
The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials
Bei Pan, Long Ge, Honghao Lai, et al.
Drugs (2023) Vol. 83, Iss. 7, pp. 587-619
Closed Access | Times Cited: 18
Bei Pan, Long Ge, Honghao Lai, et al.
Drugs (2023) Vol. 83, Iss. 7, pp. 587-619
Closed Access | Times Cited: 18
The Co-occurrence of Depression and Obesity
Roger S. McIntyre
The Journal of Clinical Psychiatry (2024) Vol. 85, Iss. 2
Open Access | Times Cited: 6
Roger S. McIntyre
The Journal of Clinical Psychiatry (2024) Vol. 85, Iss. 2
Open Access | Times Cited: 6
Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 15
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 15
Orexins and primary headaches: an overview of the neurobiology and clinical impact
Emily C. Stanyer, Jan Hoffmann, Philip R. Holland
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 5, pp. 487-496
Open Access | Times Cited: 5
Emily C. Stanyer, Jan Hoffmann, Philip R. Holland
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 5, pp. 487-496
Open Access | Times Cited: 5
Pain-Insomnia-Depression Syndrome: Triangular Relationships, Pathobiological Correlations, Current Treatment Modalities, and Future Direction
Murtaza Haidary, Shamim Arif, Dawood Hossaini, et al.
Pain and Therapy (2024) Vol. 13, Iss. 4, pp. 733-744
Open Access | Times Cited: 5
Murtaza Haidary, Shamim Arif, Dawood Hossaini, et al.
Pain and Therapy (2024) Vol. 13, Iss. 4, pp. 733-744
Open Access | Times Cited: 5
Obstructive sleep apnea syndrome, orexin, and sleep–wake cycle: The link with the neurodegeneration
Mariana Fernandes, Claudio Liguori
Handbook of clinical neurology (2025), pp. 141-160
Closed Access
Mariana Fernandes, Claudio Liguori
Handbook of clinical neurology (2025), pp. 141-160
Closed Access
Orexin Receptor Antagonists for Insomnia in Patients with Serious Illness #496
Hana Yu, Brooke Cline
Journal of Palliative Medicine (2025)
Closed Access
Hana Yu, Brooke Cline
Journal of Palliative Medicine (2025)
Closed Access
Pharmacological and psychological approaches to insomnia treatment in cardiac patients: a narrative literature review
Britta Stapel, Marlies Alvarenga, Kai G. Kahl
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Britta Stapel, Marlies Alvarenga, Kai G. Kahl
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Safety of dual orexin receptor antagonists: a real-world pharmacovigilance study
Yu Sun, Tao Xu, Hongbin Xu
Expert Opinion on Drug Safety (2025)
Closed Access
Yu Sun, Tao Xu, Hongbin Xu
Expert Opinion on Drug Safety (2025)
Closed Access
Alluring Potential to Accelerate Emergence and Ameliorate Opioid-induced Respiratory Depression without Antagonizing Analgesia: Danavorexton Enters the Anesthetic Landscape
Toshihiro Imamura, Max B. Kelz
Anesthesiology (2025) Vol. 142, Iss. 4, pp. 589-592
Closed Access
Toshihiro Imamura, Max B. Kelz
Anesthesiology (2025) Vol. 142, Iss. 4, pp. 589-592
Closed Access
Sleep Disorders: Pathogenesis and Therapeutic Interventions
Cheng Liu, Zhigang He, Yanqiong Wu, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Cheng Liu, Zhigang He, Yanqiong Wu, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Orexin Receptor Antagonists and Insomnia
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
Daridorexant for the treatment of insomnia disorder: A systematic review and meta-analysis of randomized controlled trials
Feiyu Jiang, Hang Li, Yanting Chen, et al.
Medicine (2023) Vol. 102, Iss. 7, pp. e32754-e32754
Open Access | Times Cited: 12
Feiyu Jiang, Hang Li, Yanting Chen, et al.
Medicine (2023) Vol. 102, Iss. 7, pp. e32754-e32754
Open Access | Times Cited: 12
Role of the orexin system in the bidirectional relation between sleep and epilepsy: New chances for patients with epilepsy by the antagonism to orexin receptors?
Chiara Berteotti, Carmen Calvello, Claudio Liguori
Epilepsia (2023) Vol. 64, Iss. 8, pp. 1991-2005
Open Access | Times Cited: 12
Chiara Berteotti, Carmen Calvello, Claudio Liguori
Epilepsia (2023) Vol. 64, Iss. 8, pp. 1991-2005
Open Access | Times Cited: 12
Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis
Hyun-jin Na, Nakyung Jeon, Christine E. Staatz, et al.
SLEEP (2023) Vol. 47, Iss. 2
Closed Access | Times Cited: 12
Hyun-jin Na, Nakyung Jeon, Christine E. Staatz, et al.
SLEEP (2023) Vol. 47, Iss. 2
Closed Access | Times Cited: 12
Dual orexin receptor antagonists for the treatment of insomnia: systematic review and network meta-analysis
Rebeka Bustamante Rocha, Fernanda Ferreira Bomtempo, Gabriela Borges Nager, et al.
Arquivos de Neuro-Psiquiatria (2023) Vol. 81, Iss. 05, pp. 475-483
Open Access | Times Cited: 11
Rebeka Bustamante Rocha, Fernanda Ferreira Bomtempo, Gabriela Borges Nager, et al.
Arquivos de Neuro-Psiquiatria (2023) Vol. 81, Iss. 05, pp. 475-483
Open Access | Times Cited: 11
Comparative efficacy and acceptability of psychotherapies, pharmacotherapies, and their combination for the treatment of adult insomnia: A systematic review and network meta-analysis
Ye Zhang, Rong Ren, Linghui Yang, et al.
Sleep Medicine Reviews (2022) Vol. 65, pp. 101687-101687
Closed Access | Times Cited: 18
Ye Zhang, Rong Ren, Linghui Yang, et al.
Sleep Medicine Reviews (2022) Vol. 65, pp. 101687-101687
Closed Access | Times Cited: 18
Orexin Receptor Antagonists in the Treatment of Depression: A Leading Article Summarising Pre-clinical and Clinical Studies
Harry Fagan, Edward G. Jones, David S. Baldwin
CNS Drugs (2022) Vol. 37, Iss. 1, pp. 1-12
Closed Access | Times Cited: 17
Harry Fagan, Edward G. Jones, David S. Baldwin
CNS Drugs (2022) Vol. 37, Iss. 1, pp. 1-12
Closed Access | Times Cited: 17
